)
Edge10 Jul 2026
Inside Take-Two: The Grand Anticipation
The story of how Take-Two Interactive built the empire behind Grand Theft Auto, Red Dead Redemption, and one of gaming's largest mobile portfolios.
Oxygenta Pharmaceutical
Oxygenta Pharmaceutical (524636) investor relations material
Oxygenta Pharmaceutical Q1 26/27 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 26/27 earnings summary27 Jul, 2026
Executive summary
Board approved unaudited financial results for the quarter ended 30 June 2026 and scheduled the AGM for 21 August 2026 via video conferencing.
Appointment of PCR & Associates as Cost Auditors for FY 2026-27 was approved.
Reconstitution of the POSH Committee was completed.
Financial highlights
Revenue from operations for Q1 FY 2026-27 was ₹3,699.69 lakhs, up from ₹1,513.47 lakhs in Q1 FY 2025-26.
Total expenses for the quarter were ₹3,952.75 lakhs, compared to ₹2,343.99 lakhs in the same quarter last year.
Loss before tax for the quarter was ₹250.73 lakhs, an improvement from a loss of ₹814.80 lakhs year-over-year.
Basic and diluted EPS for the quarter were both (₹0.57), compared to (₹1.65) in Q1 FY 2025-26.
Outlook and guidance
The company is actively working to complete identification of MSME creditors and has requested self-declarations from suppliers.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Oxygenta Pharmaceutical
- FY26 revenue rose but net loss deepened; board changes and compliance focus highlighted.524636
Q4 25/2623 May 2026 - Revenue rose but net losses widened in Q3 FY26; compliance and creditor processes are ongoing.524636Q3 25/264 Feb 2026
- Revenue surged in FY25, but losses deepened amid compliance and reporting challenges.524636Q4 24/2520 Nov 2025
- Q3 FY25 revenue surged, but losses deepened and compliance issues remain under review.524636Q3 24/2520 Nov 2025
- Q2 FY25 revenue grew and net loss narrowed, with key statutory and compliance actions taken.524636Q2 24/2520 Nov 2025
- Q1 FY25 revenue up, net loss narrows, equity raised via share allotment; compliance issues persist.524636Q1 24/2520 Nov 2025
- Revenue rose modestly, but losses widened; new CFO appointed and compliance efforts ongoing.524636Q2 25/267 Nov 2025
- Q1 FY26 saw higher revenue but a deeper net loss, with new auditor and compliance appointments.524636Q1 25/2619 Aug 2025
Next Oxygenta Pharmaceutical earnings date
Q2 26/2714 Nov, 2026
Oxygenta Pharmaceutical
Next Oxygenta Pharmaceutical earnings date
Q2 26/2714 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage